Inherited hepatic enzyme defects as candidates for liver-directed gene therapy.
Horwich
A L
AL
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510.
D000818:Animals; D004247:DNA / Q000032:analysis; D005260:Female; D005814:Genes, Viral; D015316:Genetic Therapy; D006801:Humans; D006867:Hydrolases / Q000172:deficiency* / Q000235:genetics; D008107:Liver Diseases / Q000151:congenital* / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D051379:Mice; D009954:Ornithine Carbamoyltransferase / Q000235:genetics; D020163:Ornithine Carbamoyltransferase Deficiency Disease; D011379:Prognosis; D014443:Tyrosine / Q000097:blood*
D014443:Tyrosine; D004247:DNA; D009954:Ornithine Carbamoyltransferase; D006867:Hydrolases; C020156:fumarylacetoacetase